FTC Leaves Supplement Industry Still Waiting For Shift Away From RCT Standard For Claims
This article was originally published in The Tan Sheet
FTC's "standard is the same. There's not any per se lower standard for substantiation just because you position your product as a supplement," says agency attorney Michelle Rusk. Supplement industry stakeholders, though, argue that FTC has no basis to require RCTs for structure/function claims.
You may also be interested in...
District court erred in dismissing FTC complaint that Prevagen marketer Quincy Biosciences used deceptive representations in ads, Second Circuit says in long-awaited order. FTC and New York attorney general, along with advocacy group TINA, criticize Quincy's post hoc data analyses finding "false positives."
“The industry would face confusion as to the appropriate substantiation standard for non-disease dietary supplement claims,” say the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a joint amicus brief filed with in Second Circuit. They submitted the brief in support of Quincy’s motion urging the appeals court to dismiss an appeal by FTC and New York of a federal district court’s 2017 dismissal of the federal and state agencies' complaint against Quincy.
Confirmations by the Senate mark FTC ’s first-ever complete leadership turnover at once and fill out the roster for the first time since President Trump’s election in 2016. The agency has been operating with two commissioners since soon after the election.